Here are six updates on GI companies from the past week.
Exact Sciences sold an additional 7 million shares for a gross proceeds of $245 million.
Valeant Pharmaceuticals added billionaire hedge fund manager John Paulson to its board of directors.
GI Dynamics added Francesco Rubino, MD, and Philip Schauer, MD, to its scientific advisory board.
Q BioMed finalized an agreement with The Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology to develop a novel liver cancer chemotherapy.
S&S Plastics and StarMed collaborated on an endoscopy bottle top to keep camera lenses clean during procedures.
The Taiwan Government Industrial Development Bureau awarded CellMax Life a $760,846 grant for its cancer detection platform.